Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

No phase data

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT07510724Recruiting
Real-World Data on the Treatment of Lung Cancer Patients With the Immune-Checkpoint Inhibitor Tislelizumab
Lung Cancer (Diagnosis)Non-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
PrincipalinvestigatorStart date: 2025-12-23

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Krankenhaus Nordwest, Frankfurt, Deutschland

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Raoul De Jonge, Dr.

Universitätsklinikum St. Pölten - Lilienfeld, Österreich

Moderately Similar
1 trials

Shared therapeutic areas:

Lung Cancer (Diagnosis)Carcinoma, Non-Small-Cell LungSmall Cell Lung Cancer (SCLC)

Worked with same sponsors:

BeOne MedicinesInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Collaborated on 1 trial
Similarity Score34%

Ciro Gallo, M.D., Ph.D.

University of Campania Luigi Vanvitelli

Related
8 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score10%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score10%

Toshimitsu Tokimoto

Astrazeneca KK

Related
16 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score10%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score10%

Zhaohui Zhu, MD

Peking Union Medical College Hospital

Related
19 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score10%

Zhengfei Zhu, MD

Fudan University

Related
8 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score10%

You Lu, MD

West China Hospital

Related
18 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score10%

Urielle Desalbres

Assistance Publique Hôpitaux de Marseille

Related
71 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score10%

Francesco Perrone, M.D., Ph.D.

National Cancer Institute, Naples

Related
13 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07510724PrincipalInvestigator

Real-World Data on the Treatment of Lung Cancer Patients With the Immune-Checkpoint Inhibitor Tislelizumab

Lung Cancer (Diagnosis)Non-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Recruiting

All 1 trials loaded